Carlos A. Garay

Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial

Mace L. Rothenberg, Amit M. Oza, Robert Bigelow et al. · Journal of Clinical Oncology · 2003 · 642 citations

Multicenter Phase I-II Trial of Docetaxel, Cisplatin, and Fluorouracil Induction Chemotherapy for Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck

Marshall R. Posner, Bonnie S. Glisson, Gary Frenette et al. · Journal of Clinical Oncology · 2001 · 153 citations

Randomized Multicenter Phase II Trial of Bolus Plus Infusional Fluorouracil/Leucovorin Compared With Fluorouracil/Leucovorin Plus Oxaliplatin As Third-Line Treatment of Patients With Advanced Colorectal Cancer

Nancy E. Kemeny, Carlos A. Garay, Jayne Gurtler et al. · Journal of Clinical Oncology · 2004 · 73 citations · Full text

Oxaliplatin Plus Irinotecan Compared With Irinotecan Alone as Second-Line Treatment After Single-Agent Fluoropyrimidine Therapy for Metastatic Colorectal Carcinoma

Daniel G. Haller, Mace L. Rothenberg, A. Wong et al. · Journal of Clinical Oncology · 2008 · 58 citations · Full text

Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma

Michael K. Wong, Ateesha F. Mohamed, Brett Hauber et al. · Journal of Medical Economics · 2012 · 41 citations